Carregant...
Prevention of Experimental Coronavirus Colds with Intranasal α-2b Interferon
Fifty-five volunteers treated with either intranasal recombinant interferon (rIFN; 2 × 10(6) IU/day) or placebo for 15 days were exposed to coronavirus by direct intranasal inoculation on the eighth day of treatment. Symptom scores were recorded, and cultures of virus were taken daily for all volunt...
Guardat en:
| Publicat a: | J Infect Dis |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The University of Chicago Press
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7110151/ https://ncbi.nlm.nih.gov/pubmed/3016111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/154.3.443 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|